Amicus Therapeutics Inc (NASDAQ:FOLD)

8.76
Delayed Data
As of Feb 27
 -0.03 / -0.34%
Today’s Change
1.77
Today|||52-Week Range
9.63
+5.29%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Amicus Therapeutics Inc have a median target of 11.50, with a high estimate of 14.00 and a low estimate of 9.00. The median estimate represents a +31.28% increase from the last price of 8.76.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Amicus Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.19
Sales
$387.5K
Reporting Date
Feb 16

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 14.77%
 
 
 
 
 
 
Growthannually 24.14%
 
 
 
 
 
 

Sales

Growthquarterly 32.25%
 
 
 
 
 
 
Growthannually 380.30%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account